Last reviewed · How we verify

NCT04836039

Rehabilitation Experiences of Physiotherapists in Covid-19 Outbreak

Completed Last updated 8 April 2021
What this trial tests

trial testing A questionnaire and scales. in Physical Therapy in 400 participants. Completed in 27 February 2021.

Timeline
27 January 2021
Primary endpoint
27 February 2021
27 February 2021

Quick facts

Lead sponsorMedipol University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment400
Start date27 January 2021
Primary completion27 February 2021
Estimated completion27 February 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Medipol University

Who can join

Adults 22 to 65, any sex, with Physical Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the process experienced by physiotherapists while providing rehabilitation services during the epidemic and to investigate the procedures adopted by physiotherapists who are currently working. In addition, by analyzing the effects of both the pandemic and the clinical and educational organizations in the Physiotherapy and Rehabilitation Clinics where physiotherapists were working during the COVID-19 epidemic, the needs arising after the pandemic can be reported. Assessments will be carried out by researcher physiotherapists through a questionnaire based on research and examples in the literature, and scales measuring anxiety, depression and stress levels. The measurement tool will be the online survey application.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Physical Therapy

Currently open trials in the same condition.

Other Medipol University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04836039.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing